HDAC9 and colorectal carcinoma: Combined treatment with an HDAC inhibitor and B7x neutralizing antibody increased the infiltration of CD8 + and CD4 + T cells in CRC tissue from metastatic tumor xenografts and reduced the lung metastasis of the CRC model[44].